Young Suk Oh MD MS
Advanced Endoscopic Interventional, Biliary Tract Disease, Inflammatory Bowel Disease, Pancreas Disease
Executive Director, Gastroenterology Clinical Team Lead Bristol Myers Squibb
Join to View Full Profile
3801 Miranda AvePalo Alto, CA 94304
Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of WisconsinMS, Clinical and Translational Science, 2010 - 2014
University of Pennsylvania Health SystemFellowship, Gastroenterology, 2006 - 2007
Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 2003 - 2006- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2003
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2000 - 2001
University of Texas Southwestern Medical SchoolClass of 2000
University of MichiganBSE, Chemical Engineering, 1992 - 1996
Certifications & Licensure
CA State Medical License 2015 - 2026
WI State Medical License 2009 - 2025
WA State Medical License 2007 - 2009
PA State Medical License 2006 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 13 citationsDeclining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, Harris A Ahmad, Shashi Adsul
Journal of Crohn's & Colitis. 2023-07-05 - 57 citationsEtrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez
The Lancet. Gastroenterology & Hepatology. 2021-11-17 - 42 citationsEtrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3...Severine Vermeire, Peter L. Lakatos, Timothy Ritter, Stephen B. Hanauer, Brian Bressler
The Lancet. Gastroenterology & Hepatology. 2021-11-16
Committees
- Member, Membership and Diversity Committee, American Society for Gastrointestinal Endoscopy 2015 - Present
- Member, Publications Committee, American College of Gastroenterology 2013 - Present
- Member, Editorial Board, Gastrointestinal Endoscopy 2011 - 2015
Professional Memberships
- Member
- Fellow
- Member
Industry Relationships
- Consultant, Boston Scientific Corporation2011 - 2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
